Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Nearly all elderly nursing home residents had a skin disease, with dry skin being the most common.

Enteral nutrition's role in maintaining Crohn's disease remission is unclear and needs more research.

Malassezia infection may cause refractory acne, and antifungal treatments can help.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Atopic dermatitis and alopecia areata have a major global socioeconomic impact, needing more research and better healthcare alignment.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Periplaneta americana extract helps hair regrowth by reducing inflammation and improving skin bacteria balance.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.